Exosome Diagnostics Places Its First Early Access Shahky System within a Top 15 Pharmaceutical Laboratory
08 janv. 2018 07h56 HE
|
Exosome Diagnostics
Waltham, MA, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics has announced the placement of the world’s first system for exosome specific protein analysis, the Shahky system, within a large...
Top 10 Global Pharmaceutical Manufacturer Sets New Standard for Product Integrity With NanoGuardian
13 févr. 2012 09h30 HE
|
NanoGuardian
SKOKIE, IL--(Marketwire - Feb 13, 2012) - NanoGuardian™, a division of NanoInk®, Inc. that delivers on-dose brand protection solutions to fight illegal diversion and counterfeiting,...
Aegerion Pharmaceuticals to Present at the 2011 Canaccord Genuity Growth Conference
04 août 2011 08h00 HE
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Aug. 4, 2011 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
Preliminary Data From Exploratory Phase II Study Demonstrates Significant Activity of Droxidopa in Adult Attention Deficit Hyperactivity Disorder (ADHD)
26 juil. 2011 08h00 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., July 26, 2011 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced positive top-line results of an investigator-led Phase II clinical study of...
Myrexis Announces Executive Management Changes
22 juil. 2011 08h30 HE
|
Myrexis, Inc.
SALT LAKE CITY, July 22, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on developing and commercializing novel treatments for cancer, today announced that...
Myrexis to Participate in Stifel Nicolaus 2011 Orphan Drug One-on-One Conference
30 juin 2011 16h00 HE
|
Myrexis, Inc.
SALT LAKE CITY, June 30, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on developing and commercializing novel treatments for cancer, today announced that...
Semafore Pharmaceuticals Reports New Preclinical Data for Multi-Kinase, PI3K/mTOR Inhibitor SF1126 at AACR
05 avr. 2011 13h00 HE
|
Semafore Pharmaceuticals
INDIANAPOLIS, April 5, 2011 (GLOBE NEWSWIRE) -- Semafore Pharmaceuticals today announced encouraging preclinical results for its lead product candidate, SF1126, in certain B-cell malignancies. The...
Graymark Healthcare Reports Fiscal 2008 Year End Results
01 avr. 2009 08h30 HE
|
Graymark Healthcare, Inc.
OKLAHOMA CITY, April 1, 2009 (GLOBE NEWSWIRE) -- Graymark Healthcare Inc. (Nasdaq:GRMH) today announced results for the year ended December 31, 2008.
During the year ended December 31, 2008, net...
CombiMatrix Announces Positive Preliminary Data on Non-Invasive, Cancer Screening Test
26 févr. 2009 06h00 HE
|
CombiMatrix Corporation
MUKILTEO, Wash., Feb. 26, 2009 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) today announced positive preliminary data on its investigational Comprehensive Cancer Array (CCA) test showing...
Tongli Pharmaceuticals Announces Strong Revenue and Net Income Growth in Third Quarter of Fiscal Year 2009
17 févr. 2009 09h00 HE
|
Tongli Pharmaceuticals (USA), Inc.
NEW YORK, N.Y., Feb. 17, 2009 (GLOBE NEWSWIRE) -- Tongli Pharmaceuticals (OTCBB:TGLP), a pharmaceutical company specializing in the development, manufacture, and commercialization in the People's...